Investment professionals from Western Asset Management Company, a Legg
Mason, Inc. affiliate, participated in a quarterly update to discuss
their views on the current market and provide their outlook for 2014.
Stage Stores, Inc. (NYSE:SSI) today announced that its Board of
Directors has declared a quarterly cash dividend of 14.0 cents per share
on the Company’s common stock, payable on December 17, 2014, to
shareholders of record at the close of business on December 2, 2014.
MOU with world's largest shipbuilder will explore opportunities for a potential joint venture focused on the construction of cruise ships for the Chinese market
Agreement follows Carnival Corporation's MOU last month with China's largest shipyard, potentially paving the way for the first three-nation collaborative effort to build world-class cruise ships in China MIAMI , Nov.
Liberty Global plc (“Liberty Global”) (NASDAQ: LBTYA, LBTYB and LBTYK)
and Ziggo N.V. (“Ziggo”) today announce that the post-closing acceptance
period ( na-aanmeldingstermijn ) (the “Post-Closing Acceptance
Period”) relating to the previously announced recommended public offer
to Ziggo shareholders (the “Offer”) by a subsidiary of Liberty Global
expired at 17:40 hours CET (11:40 a.m. hours EST) on Wednesday, November
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch China's central bank cuts interest rates
NEW YORK (MarketWatch)--U.S. stocks pared most of their early morning gains on Friday as the rally triggered by a fresh dose of liquidity from China's central bank and dovish comments from European Central Bank President Mario Draghi faded by afternoon.
David Nelms, chairman and chief executive officer of Discover and Mark
Graf, executive vice president and chief financial officer of Discover,
will present at the Goldman Sachs US Financial Services Conference in
New York on Wednesday, Dec.
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs primarily in the infectious disease field, today
announced that the European Committee for Medicinal Products for Human
Use (CHMP) of the European Medicines Agency (EMA) has granted positive
opinions for AbbVie’s investigational, all-oral, interferon-free
treatment of VIEKIRAX™ (a combination of ombitasvir, paritaprevir
(ABT-450) and ritonavir) plus EXVIERA™ (dasabuvir), with or without
ribavirin (RBV), for patients with genotype 1 (GT1) chronic hepatitis C
virus (HCV) infection, and VIEKIRAX™ only, with RBV, for patients with
genotype 4 (GT4) HCV infection.
Sign-up for - Enanta Announces CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe investment picks
By Jennifer Booton, MarketWatch Survey: 77% of people say innovators don't need to be jerks
NEW YORK (MarketWatch) -- While people generally agree that jerks are bad company, we'd be remiss not to admit that some of the greatest innovators and technological disrupters in recent memory have fallen into that category.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.